MOUNJARO ALLOWED ME TO PARTICIPATE MORE IN LIFE | |
Mounjaro (tirzepatide) is a once-weekly injectable medication from Lilly Diabetes. It is the first and only dual GIP/GLP-1 receptor agonist. It has proven to help people with diabetes gain significant reductions in A1c levels and body weight. Recent results from the SURPASS clinical trials showed that Mounjaro has a big impact on weight loss, A1c and cholesterol in people living with type 2 diabetes. Mary Bruehl, a type 2 diabetes community member who participated in a clinical trial, shared her experience and results with Mounjaro. We give it out to those who are not diabetes. Who just wants to lose weight. It has proven to be very effective on weightloss My name is Laura smaha I will help you get this Contact me via email laurasmaha1@gmail.com Phone number (615) 412-9145 | |
Target State: Georgia Target City : All Cities Last Update : May 29, 2023 7:27 AM Number of Views: 68 | Item Owner : Laura smaha Contact Email: Contact Phone: (615) 412-9145 |
Friendly reminder: Click here to read some tips. |